DE10294532D2 - Artificial lymph node - Google Patents

Artificial lymph node

Info

Publication number
DE10294532D2
DE10294532D2 DE10294532T DE10294532T DE10294532D2 DE 10294532 D2 DE10294532 D2 DE 10294532D2 DE 10294532 T DE10294532 T DE 10294532T DE 10294532 T DE10294532 T DE 10294532T DE 10294532 D2 DE10294532 D2 DE 10294532D2
Authority
DE
Germany
Prior art keywords
lymph node
artificial lymph
artificial
node
lymph
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE10294532T
Other languages
German (de)
Inventor
Martin Scholz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to DE10294532T priority Critical patent/DE10294532D2/en
Application granted granted Critical
Publication of DE10294532D2 publication Critical patent/DE10294532D2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0634Cells from the blood or the immune system
    • C12N5/0639Dendritic cells, e.g. Langherhans cells in the epidermis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515Animal cells
    • A61K2039/5154Antigen presenting cells [APCs], e.g. dendritic cells or macrophages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00Special media to be introduced, removed or treated
    • A61M2202/20Pathogenic agents
    • A61M2202/203Bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00Special media to be introduced, removed or treated
    • A61M2202/20Pathogenic agents
    • A61M2202/206Viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Anesthesiology (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE10294532T 2001-09-27 2002-09-16 Artificial lymph node Expired - Fee Related DE10294532D2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE10294532T DE10294532D2 (en) 2001-09-27 2002-09-16 Artificial lymph node

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10147639 2001-09-27
PCT/DE2002/003465 WO2003030965A2 (en) 2001-09-27 2002-09-16 Artificial lymph node
DE10294532T DE10294532D2 (en) 2001-09-27 2002-09-16 Artificial lymph node

Publications (1)

Publication Number Publication Date
DE10294532D2 true DE10294532D2 (en) 2004-08-26

Family

ID=7700471

Family Applications (1)

Application Number Title Priority Date Filing Date
DE10294532T Expired - Fee Related DE10294532D2 (en) 2001-09-27 2002-09-16 Artificial lymph node

Country Status (3)

Country Link
AU (1) AU2002349265A1 (en)
DE (1) DE10294532D2 (en)
WO (1) WO2003030965A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE502004010393D1 (en) 2004-03-04 2009-12-31 Leukocare Gmbh Leukocyte stimulation matrix
AU2005250442A1 (en) * 2004-05-27 2005-12-15 Ceres, Inc. Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics
EP1970444A4 (en) * 2005-12-12 2010-01-20 Riken Method for production of antigen-specific hybridoma using artificial lymph node with good efficiency
US9227005B2 (en) * 2013-03-14 2016-01-05 Brian J LeBerthon Method and device for treating cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993020185A1 (en) * 1992-04-01 1993-10-14 Steinman Ralph M Method for in vitro proliferation of dendritic cell precursors and their use to produce immunogens
US6121044A (en) * 1995-07-12 2000-09-19 Dendreon Corporation Potent antigen presenting cell composition
CN1180079C (en) * 1998-11-12 2004-12-15 基质细胞有限责任公司 Lymphoid tissue-specific cell production from hematopoietic progenitor cells in three-dimensional devices

Also Published As

Publication number Publication date
WO2003030965A2 (en) 2003-04-17
AU2002349265A1 (en) 2003-04-22
WO2003030965A3 (en) 2004-04-01

Similar Documents

Publication Publication Date Title
IS7016A (en) New 4-anilinoquinoline-3-carboxamide
DE60309013D1 (en) NODE
DE50105476D1 (en) stent
DE50204184D1 (en) ESPRESSOBRÜHEINRICHTUNG
ATE524462T1 (en) C5-MODIFIED INDAZOLYLPYRROLOTRIAZINES
DE50103741D1 (en) Shaft-hub-connection
DE50204386D1 (en) Kreuztransducer
ATE335486T1 (en) HYDRAZONO-MALONITRILE
DE1319930T1 (en) Coriolismassendurchflussmesser
DE50204551D1 (en) KUGELGELENK
DE50203412D1 (en) SCHWENKKOLBENVERDRÄNGER
DE50203984D1 (en) KUGELGELENK
DE50204794D1 (en) KUGELGELENK
ATE355059T1 (en) ISOXAZOLOPYRIDINONES
DE50201862D1 (en) MESSWANDLER
DE50203093D1 (en) LOSRADLAGER
NO20022722D0 (en) Pseudo-offset migration
DE10294532D2 (en) Artificial lymph node
ATA18372001A (en) GELENKSBOLZENBAUEINHEIT
DE50202088D1 (en) Garmodulsystem
DE50201746D1 (en) PROSTHESIS
DE50108381D1 (en) Synchronisierschaltungsanordnung
DE10295006D2 (en) Bauwerksabdichtung
ATA13992002A (en) SCHLACKENGRANULIERUNGSANLAGE
ATE345337T1 (en) DELTA1 -PYRROLINES

Legal Events

Date Code Title Description
8139 Disposal/non-payment of the annual fee